European regulatory authority adopts positive opinion for Novo Nordisk's Alhemo\u00ae (concizumab), recommending label expansion

• click to rate

  Posted by Two Blokes Jul 25 - Filed in Stock - 4 views
  
  Bagsværd, Denmark, 25 July 2025 – Novo Nordisk today announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion, recommending an update of the Alhemo\u00ae (concizumab) label to include the treatment of severe haemophilia A and moderate or severe haemophilia B without inhibitors.